Canaccord Genuity Maintains Buy on DexCom, Maintains $106 Price Target

Benzinga · 08/01 15:18
Canaccord Genuity analyst William Plovanic maintains DexCom (NASDAQ:DXCM) with a Buy and maintains $106 price target.